Page last updated: 2024-09-03

3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide and td-5108

3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide has been researched along with td-5108 in 1 studies

Compound Research Comparison

Studies
(3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide)
Trials
(3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide)
Recent Studies (post-2010)
(3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide)
Studies
(td-5108)
Trials
(td-5108)
Recent Studies (post-2010) (td-5108)
270434052216

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, KY; Danser, AH; de Vries, R; Leijten, FP; MaassenVanDenBrink, A; Pfannkuche, HJ; van den Bogaerdt, AJ1

Other Studies

1 other study(ies) available for 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide and td-5108

ArticleYear
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries.
    European journal of pharmacology, 2009, Oct-01, Volume: 619, Issue:1-3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Benzamides; Coronary Vessels; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle Contraction; Pyridines; Receptors, Serotonin, 5-HT4; RNA, Messenger; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents; Young Adult

2009